IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 18 filers reported holding IO BIOTECH INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,103,364 | +26.4% | 5,747,067 | +75.3% | 0.60% | +21.0% |
| Q2 2023 | $6,408,357 | +4.3% | 3,277,932 | 0.0% | 0.50% | +21.9% |
| Q1 2023 | $6,146,123 | -18.5% | 3,277,932 | 0.0% | 0.41% | -13.8% |
| Q4 2022 | $7,539,244 | -15.1% | 3,277,932 | 0.0% | 0.47% | +11.1% |
| Q3 2022 | $8,883,000 | -42.0% | 3,277,932 | 0.0% | 0.42% | -43.8% |
| Q2 2022 | $15,308,000 | -11.9% | 3,277,932 | 0.0% | 0.75% | -17.7% |
| Q1 2022 | $17,373,000 | -17.2% | 3,277,932 | 0.0% | 0.92% | -7.8% |
| Q4 2021 | $20,979,000 | – | 3,277,932 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 3,640,015 | $5,132,421 | 1.57% |
| Vivo Capital, LLC | 6,173,439 | $8,704,549 | 0.95% |
| Stonepine Capital Management, LLC | 1,975,308 | $2,785,184 | 0.92% |
| Novo Holdings A/S | 5,747,067 | $8,103,364 | 0.60% |
| Pivotal bioVenture Partners Investment Advisor LLC | 864,197 | $1,218,518 | 0.49% |
| Logos Global Management LP | 493,827 | $696,296 | 0.09% |
| PFM Health Sciences, LP | 1,353,453 | $1,908,369 | 0.09% |
| ARMISTICE CAPITAL, LLC | 2,148,000 | $3,028,680 | 0.05% |
| Avoro Capital Advisors LLC | 2,055,883 | $2,837,119 | 0.04% |
| Alyeska Investment Group, L.P. | 987,654 | $1,392,592 | 0.01% |